Document Classification

Section Type: RESULTS

Text: Ribavirin - and placebo-treated patient groups were not significantly different in the number of ventilator days (6. 4 + / - 6. 9 vs. 8. 2 + / - 10. 1 ; p =. 5), oxygen days (10. 8 + / - 7. 7 vs. 12. 2 + / - 11. 8 ; p =. 9), ICU days (7. 9 + / - 7. 0 vs. 10. 3 + / - 11. 0 ; p =. 7), or hospital days (12. 9 + / - 9. 7 vs. 16. 2 + / - 14. 0 ; p =. 6) after the initiation of aerosol therapy.